What is NDC 51662-1714?

51662-1714 is the product NDC for Tranexamic Acid, Tranexamic acid 100 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tranexamic Acid?

43 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tranexamic Acid NDC 51662-1714 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1714Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1714Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1714-1	5166217140151662171401	10 mL in 1 VIAL (51662-1714-1)Marketed from Jul 15, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tranexamic Acid
Generic name (nonproprietary): tranexamic acid
Active ingredients: Tranexamic acid — 100 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207239
Marketing start: Jul 15, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Fibrinolysis (Physiologic effect)
Identifiers: Product ID 51662-1714_5d570f08-eea9-71cf-e063-6294a90a5b46SPL ID 5d570f08-eea9-71cf-e063-6294a90a5b46
Pharmacologic class: Antifibrinolytic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662171401 followed by a unit qualifier and the quantity

Package 51662-1714-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 51662-1714

What is NDC 51662-1714?: 51662-1714 is the product NDC for Tranexamic Acid, Tranexamic acid 100 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tranexamic Acid.
What is the active ingredient?: Tranexamic acid.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tranexamic Acid?: 43 other product NDCs are listed under this name. See all Tranexamic Acid NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tranexamic Acid NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	NorthStar Rx LLC	72603-818	72603-0818-01
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	i3 Pharmaceuticals, LLC	72319-028	72319-0028-01
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	Dr. Reddy's Laboratories Inc.	75907-309	75907-0309-30
Tranexamic Acid	Tranexamic acid 100 mg/mL	InjectionIntravenous	Caplin Steriles Limited	65145-106	65145-0106-10
Tranexamic Acid	Tranexamic acid 100 mg/mL	InjectionIntravenous	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-909	23155-0909-41
Tranexamic Acid	Tranexamic acid 100 mg/mL	InjectionIntravenous	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-910	23155-0910-41
Tranexamic Acid	Tranexamic acid 100 mg/mL	InjectionIntravenous	Northstar Rx LLC	72603-387	72603-0387-10
Tranexamic Acid	Tranexamic acid 1 g/10mL	Injection, SolutionIntravenous	Emcure Pharmaceuticals Limited	14593-318	14593-0318-01
Tranexamic Acid	Tranexamic acid 10 mg/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-418	25021-0418-82
Tranexamic Acid	Tranexamic acid 10 mg/mL	Injection, SolutionIntravenous	Nexus Pharmaceuticals LLC	14789-115	14789-0115-05

All 44 Tranexamic Acid NDCs

Other NDCs under ANDA 207239

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207239
Product	Strength	Form · route	Labeler	Product NDC
Tranexamic Acid	Tranexamic acid 100 mg/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-415
Tranexamic acid	Tranexamic acid 100 mg/mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-160